Literature DB >> 1623669

Diagnostic imaging in hypertrophic osteoarthropathy.

C Pineda1.   

Abstract

This review discusses our experience with conventional radiography and advanced imaging techniques in the evaluation of diverse soft tissue, skeletal and joint abnormalities frequently observed in patients with both the primary and secondary forms of hypertrophic osteoarthropathy. The manifestations include finger clubbing, elephant feet, cutis verticis gyrata, synovial effusion, periostosis, tuftal hypertrophy and acro-osteolysis. Its coexistence with other skeletal and joint diseases and its imaging differential diagnosis are also reviewed.

Entities:  

Mesh:

Year:  1992        PMID: 1623669

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

Review 1.  Joint disorders in cystic fibrosis.

Authors:  M A Turner; E Baildam; L Patel; T J David
Journal:  J R Soc Med       Date:  1997       Impact factor: 5.344

2.  Two cases with pachydermoperiostosis and discussion of tamoxifen citrate treatment for arthralgia.

Authors:  Aysenur Okten; Ilke Mungan; Mukaddes Kalyoncu; Zerrin Orbak
Journal:  Clin Rheumatol       Date:  2007-01       Impact factor: 2.980

3.  A case report of disabling bone pain after long-term kidney transplantation.

Authors:  T M M Myint; M Vucak-Dzumhur; P R Ebeling; G J Elder
Journal:  Osteoporos Int       Date:  2013-06-26       Impact factor: 4.507

4.  Hypertrophic osteoarthropathy: endothelium and platelet function.

Authors:  F Silveri; R De Angelis; F Argentati; D Brecciaroli; S Muti; C Cervini
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

Review 5.  Primary hypertrophic osteoarthropathy: ultrasound and MRI findings.

Authors:  Brook Adams; Tania Amin; Valentina Leone; Mark Wood; Jeannette K Kraft
Journal:  Pediatr Radiol       Date:  2016-03-03

6.  The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation.

Authors:  Qianqian Pang; Yuping Xu; Xuan Qi; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Ling Qin; Weibo Xia
Journal:  Endocr Connect       Date:  2019-06       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.